State of the ART: Clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 21, Issue 11, 2009, Pages 1401-1411

  Wouters, E ^a   Van Loon, F ^a   Van Rensburg, D ^b   Meulemans, H ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF THE FREE STATE   (South Africa)

Author keywords

Antiretroviral treatment; Clinical outcomes; HIV AIDS; Quality of life; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTHRALGIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; DIARRHEA; DIZZINESS; DRUG TREATMENT FAILURE; FATIGUE; FEMALE; HEALTH PROGRAM; HEALTH SERVICE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; SCORING SYSTEM; SKIN DISEASE; SOUTH AFRICA; THERAPY EFFECT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; QUALITY OF LIFE; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 77649310249     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120902884034     Document Type: Article

References (63)

1. Aaronson, N.K., Meyerowitz, B.E., Bard, M., Bloom, J.R., Fawzy, F.I., Feldstein, M., et al. (1991). Quality of life research in oncology: Past achievements and future priorities. Cancer, 67(Suppl. 3), 839-843.
2. Ahdieh Grant, L., Silverberg, M.J., Palacio, H., Minkoff, H., Anastos, K., Young, M.A., et al. (2001). Discontinuation of potent antiretroviral therapy: Predictive value of and impact on CD4 cell counts and HIV RNA levels. AIDS, 15(16), 2101-2108. (Pubitemid 33101817)
3. Baggaley, R.F. (2006). Antiretroviral use in resource-poor settings: Modeling its impact. PLoS Medicine, 3(4), e179.
4. Baggaley, R.F., Ferguson, N.M., & Garnett, G.P. (2005). The epidemiological impact of antiretroviral use predicted by mathematical models: A review. Emerging Themes in Epidemiology, 2(9), 1-18.
5. Berzon, R.A., Leplege, A.P., Lohr, K.N., Lenderking, W.R., & Wu, A.W. (1997). Summary and recommendations for future research. Quality of Life Research, 6(6), 601-605.
6. Bisson, G.P., Gross, R., Strom, J.B., Rollins, C., Bellamy, S., Weinstein, R., et al. (2006). Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy. AIDS, 20(12), 1613-1619. (Pubitemid 44162403)
7. Bloom, J., Obiero, W., Kabore, I., Wanless, S., & Mtshali, P. (2006, August 13-18). The impact of family and community support on quality of life (QoL) for antiretroviral (ARV) clients: Findings from enhanced evaluation in Botswana, Lesotho, Namibia and South Africa. Paper presented at the XVI international AIDS conference, Toronto, Canada.
8. Bookwalter, J.T., & Dalenberg, D. (2004). Subjective wellbeing and household factors in South Africa. Social Indicators Research, 65(3), 333-353. (Pubitemid 38237584)
9. Braithwaite, R.S., Kozal, M.J., Chang, C.C.H., Roberts, M.S., Fultz, S.L., Goetz, M.B., et al. (2007). Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS, 21(12), 1579-1589.
10. Bratt, G., Karlsson, A., Leandersson, A-C., Albert, J., Wahren, B., & Sandströ m, E. (1998). Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment. AIDS, 12(16), 2193-2202.
11. Brigido, L., Rodrigues, R., Casseb, J., Custodio, R., Fonseca, L.A.M., Sanchez, M., et al. (2004). CD4- T-cell recovery and clinical outcome in HIV-1-infected patients exposed to multiple antiretroviral regimens: Partial control of viremia is associated with favorable outcome. AIDS Patient Care & STDs, 18(4), 189-198.
12. Burgess, A.P., Carretero, M., Elkington, A., Pasqual-Marsettin, E., Lobaccaro, C., & Catalan, J. (2000). The role of personality, coping style and social support in health-related quality of life in HIV infection. Quality of Life Research, 9(4), 423-437.
13. Burgess, A.P., Dayer, M., Catalan, J., Hawkins, D., & Gazzard, B. (1993). The reliability and validity of two HIV-specific health-related quality-of-life measures. AIDS, 7(7), 1001-1008.
14. (2006). A hybrid model for research on subjective well-being: Examining common- and component-specific sources of variance in life satisfaction, positive affect, and negative affect. Social Indicators Research, 83(3), 413-445.
15. Calmy, A., Hirschel, B., Cooper, D.A., & Carr, A. (2007). Clinical update: Adverse effects of antiretroviral therapy. Lancet, 370(9581), 12-14.
16. Cella, D., Chang, C-H., Wright, B.D., Von Roenn, J.H., & Skeel, R.T. (2005). Defining higher order dimensions of self-reported health: Further evidence for a twodimensional structure. Evaluations & the Health Professions, 28(2), 122-141.
17. Cella, D., Hernandez, L., Bonomi, A.E., Corona, M., Vaquero, M., Shimoto, G., et al. (1998). Spanish language translation and initial validation of the functional assessment of cancer therapy quality of life instrument. Medical Care, 36(9), 1407-1418.
18. Dal Poz, M.A., Dreesch, N., & Van Rensburg, D. (2008). Redefining HIV/AIDS care delivery in the face of human resource scarcity. In J.M. Zuniga, A. Whiteside, A. Ghaziani, & J.G. Bartlett (Eds.), A decade of HAART. The development and global impact of highly active antiretroviral therapy (pp. 477-498). Oxford: Oxford University Press.
19. Day, C., & Gray, A. (2007). Health and related indicators. In S. Harrison, R. Bhana, & A. Ntuli (Eds.), South African health review 2007 (pp. 215-344). Durban: Health Systems Trust.
20. Department of Health. (2003). Operational plan for comprehensive HIV and AIDS care, management and treatment for South Africa. Retrieved March 24, 2009, from http://www.info.gov.za/issues/hiv/careplan.htm.
21. Diener, E., Oishi, S., & Lucas, R.E. (2003). Personality, culture, and subjective well-being: Emotional and cognitive evaluations of life. Annual Review of Psychology, 54, 403-425.
22. Diener, E., Suh, E., & Oishi, S. (1997). Recent findings on subjective well-being. Indian Journal of Clinical Psychology, 24(1), 25-41.
23. Eid, M., & Diener, E. (2004). Global judgements of subjective well-being: Situational variability and longterm stability. Social Indicators Research, 65(4), 245-277.
24. Fairall, L.R., Bachmann, M.O., Louwagie, G.M.C., Van Vuuren, C., Chikobvu, P., Steyn, D., et al. (2008). Effectiveness of antiretroviral treatment in a South African program. Archives of Internal Medicine, 168(1), 86-93.
25. Ferradini, L., Laureillard, D., Prak, N., Ngeth, C., Fernandez, M., Pinoges, L., et al. (2007). Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS, 21(17), 2293-2301.
26. Gatti, G., Di Biagio, A., Casazza, R., De Pascalis, C., Bassetti, M., Cruciani, M., et al. (1999). The relationship between ritonavir plasma levels and side-effects: Implications for therapeutic drug monitoring. AIDS, 13(15), 2083-2089.
27. Hays, R.D., Cunningham, W.E., Beck, G.K., & Shapiro, M.F. (1995). Health-related quality of life in HIV disease. Assessment, 2(4), 363-380.
28. Hays, R.D., & Stewart, A.L. (1990). The structure of selfreported health in chronic disease patients. Psychological Assessment, 2(1), 22-30.
29. Holmes, W.C., & Shea, J.A. (1998). A new HIV/AIDStargeted quality of life (HAT-QOL) instrument: Development, reliability and validity. Medical Care, 36(2), 138-154.
30. Jelsma, J., Maclean, E., Hughes, J., Tinise, X., & Darder, M. (2005). An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care, 17(5), 579-588.
31. Jia, H., Uphold, C.R., Wu, S., Chen, G.J., & Duncan, P.W. (2005). Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. AIDS Patient Care & STDs, 19(6), 395-405.
32. Jia, H., Uphold, C.R., Zheng, Y., Wu, S., John Chen, G., Findley, K., et al. (2007). A further investigation of health-related quality of life over time among men with HIV infection in the HAART era. Quality of Life Research, 16(6), 961-968.
33. Kashdan, T.B. (2004). The assessment of subjective wellbeing (issues raised by the Oxford happiness questionnaire). Personality and Individual Differences, 36, 1225-1232.
34. Larson, B.A., Fox, M.P., Rosen, S., Bii, M., Sigei, C., Shaffer, D., et al. (2008). Early effects of antiretroviral therapy on work performance: Preliminary results from a cohort study of Kenyan agricultural workers. AIDS, 22(3), 421-425.
35. Lenderking, W.R., Testa, M.A., Katzenstein, D., & Hammer, S. (1997). Measuring quality of life in early HIV disease: The modular approach. Quality of Life Research, 6(6), 515-530.
36. Monforte, A.d.A., Testa, L., Adorni, F., Chiesa, E., Bini, T., Moscatelli, G.C., et al. (1998). Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS, 12(13), 1631-1637.
37. Mukherjee, J.S., Farmer, P.E., Niyizonkiza, D., McCorkle, L., Vanderwarker, C., Teixeira, P., et al. (2003). Tackling HIV in resource poor countries. British Medical Journal, 327, 1104-1106.
38. Murphy, D.A., Marelich, W.D., Hoffman, D., & Steers, W.N. (2004). Predictors of antiretroviral adherence. AIDS Care, 16(4), 471-484.
39. Mutimura, E., Stewart, A., & Crowther, N.J. (2007). Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda. AIDS Research and Therapy, 4(19), doi:10.1186/1742- 6405-4-19. (Pubitemid 350111698)
40. Nixon, S.A., & Veenstra, N. (2008). Maintaining and developing health systems to sustain HAART. In J.M. Zuniga, A. Whiteside, A. Ghaziani, & J.G. Bartlett (Eds.), A decade of HAART. The development and global impact of highly active antiretroviral therapy (pp. 463-476). Oxford: Oxford University Press.
41. O'Connell, K., Saxena, S., Skevington, S., & WHOQOL HIV Group. (2004). WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: Results from the field test. AIDS Care, 16(7), 882-889.
42. Ormel, J., Lindenberg, S., Steverink, N., & Verbrugge, L.M. (1999). Subjective well-being and social production functions. Social Indicators Research, 46(1), 61-90.
43. Paredes, R., Sherer, R., & Clotet, B. (2008). The clinical challenges of lifetime HAART. In J.M. Zuniga, A. Whiteside, A. Ghaziani, & J.G. Bartlett (Eds.), A decade of HAART. The development and global impact of highly active antiretroviral therapy (pp. 421-462). Oxford: Oxford University Press.
44. Park-Wyllie, L.Y., Strike, S., Antoniou, T., & Bayoumi, A.M. (2007). Adverse quality of life consequences of antiretroviral medications. AIDS Care, 19(2), 252-257.
45. Préau, M., Leport, C., Salmon-Ceron, D., Carrieri, P., Portier, H., Chêne, G., et al. (2004). Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care, 16(5), 649-661.
46. Revicki, D.A., Sorenson, S., & Wu, A.W. (1998). Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV health survey. Medical Care, 36(2), 126-137.
47. Rosen, S., Ketlhapile, M., Sanne, I., & Bachman DeSilva, M. (2008). Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS, 22(Suppl. 1), S131-S139.
48. Rosen, S., Sanne, I., Collier, A., & Simon, J.L. (2005). Hard choices: Rationing antiretroviral therapy for HIV/ AIDS in Africa. Lancet, 365, 354-356. (Pubitemid 40139115)
49. Schneider, H., Blaauw, D., Gilson, L., Chabikuli, N., & Goudge, J. (2006). Health systems and access to antiretroviral drugs for HIV in southern Africa: Service delivery and human resources challenges. Reproductive Health Matters, 14(27), 12-23. (Pubitemid 43732446)
50. Skevington, S., & O'Connell, K. (2003). Measuring quality of life in HIV and AIDS: A review of the recent literature. Psychology and Health, 18(3), 331-350. (Pubitemid 36795318)
51. UNAIDS, & WHO. (2008). UNAIDS/WHO epidemiological fact sheets on HIV and AIDS, 2008 update. Geneva, Switzerland: UNAIDS/WHO.
52. Van Damme, W., Kober, K., & Kegels, G. (2008). Scalingup antiretroviral treatment in Southern African countries with human resource shortage: How will health systems adapt? Social Science & Medicine, 66(10), 2108-2121. (Pubitemid 351509687)
53. Van Damme, W., Kober, K., & Laga, M. (2006). The real challenges for scaling up ART in sub-Saharan Africa. AIDS, 20(5), 653-656. (Pubitemid 43884291)
54. Van Oosterhout, J.J.G., Kumwenda, J.K., Hartung, T., Mhango, B., & Zijlstra, E.E. (2007). Can the initial success of the Malawi ART scale-up programme be sustained? The example of Queen Elizabeth central hospital, Blantyre. AIDS Care, 19(10), 1241-1246.
55. Vickrey, B.G., Hays, R.D., Harooni, R., Myers, L.W., & Ellison, G.W. (1992). A health-related quality of life instrument for patients evaluated for epilepsy surgery. Medical Care, 30(4), 299-319.
56. Ware, J.E.J., Kosinski, M., Gandek, B., Aaronson, N.K., Apolone, G., Bech, P., et al. (1998). The factor structure of the SF-36 health survey in 10 countries: Results from the IQOLA Project. Journal of Clinical Epidemiology, 51(11), 1159-1165. (Pubitemid 28527171)
57. Ware, J.E.J., Kosinski, M., & Keller, S.D. (1994). SF-36 physical and mental health summary scales: A user's manual. Boston, MA: Health Institute, New England Medical Center.
58. WHO. (2006). Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2006 revision. Geneva, Switzerland: World Health Organisation.
59. WHOQOL HIV Group. (2004). WHOQOL-HIV for quality of life assessment among people living with HIV and AIDS: Results from the field test. AIDS Care, 16(7), 882-889.
60. Wood, E., Hogg, R.S., Yip, B., Moore, D., Harrigan, P.R., & Montaner, J.S.G. (2006). Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts-or-200 cells/microliter. AIDS, 20(8), 1117-1123.
61. Wood, R., & Martin, D. (2008). Country review: South Africa. In J.M. Zuniga, A. Whiteside, A. Ghaziani, & J.G. Bartlett (Eds.), A decade of HAART. The development and global impact of highly active antiretroviral therapy (pp. 275-290). Oxford: Oxford University Press.
62. Wouters, E., Heunis, J.C., Van Rensburg, H.C.J., & Meulemans, H. (2008). Patient satisfaction with antiretroviral services at primary health-care facilities in the Free State, South Africa * a two-year study using four waves of cross-sectional data. BMC Health Services Research, 8(210), doi:10.1186/1472-6963-8-210.
63. Wouters, E., Meulemans, H., Van Rensburg, H.C.J., Mortelmans, D., & Heunis, J.C. (2007). Short-term physical and emotional health outcomes of public sector ART in the Free State province of South Africa. Quality of Life Research, 16(9), 1461-1471. (Pubitemid 47561731)